New Zealand markets close in 2 hours 14 minutes

StatSure Diagnostic Systems, Inc. (SSUR)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 02:44PM EDT

StatSure Diagnostic Systems, Inc.

1222 Avenue M
Brooklyn, NY 11230
United States
347-394-3641
https://www.statsurediagnostics.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees4

Key executives

NameTitlePayExercisedYear born
Mr. Moshe BodnerCEO, President, VP of Business Development & Director120kN/A1958
Harry AdlerChief Operating OfficerN/AN/AN/A
Amounts are as of 31 December 2007, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally. The company offers SURE CHECK HIV 1/2 and Clearview Complete HIV 1/ 2 tests, which are single-use diagnostic tests for visual detection of antibodies to HIV 1 and HIV 2. It also provides medical specimen collection devices. The company was founded in 1986 and is based in Brooklyn, New York.

Corporate governance

StatSure Diagnostic Systems, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.